• OPEN AN ACCOUNT
Indian Indices
Nifty
24,273.80 -140.60
(-0.58%)
Sensex
79,451.82 -882.99
( -1.10%)
Bank Nifty
54,365.65 -245.25
( -0.45%)
Nifty IT
36,002.45 82.15
( 0.23%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
36,949.24 169.58
(0.46%)
Nikkei 225
8,531.61 -27.72
(-0.32%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

MRF Ltd
Industry :  Tyres
BSE Code
ISIN Demat
Book Value()
500290
INE883A01011
42856.0676756
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MRF
32.29
58842.95
EPS(TTM)
Face Value()
Div & Yield %
4297.31
10
0.17
 

sanwaria consumer ltd
Cipla to infuse ZAR 900 million in Cipla Medpro South Africa Proprietary Limited
Feb 03,2025
Cipla will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the Company in South Africa (CMSA).

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical products.

The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries.